肿瘤相关巨噬细胞在胶质瘤新生血管生成中的作用及其对抗血管生成策略的启示
本文综述肿瘤相关巨噬细胞(TAM)在弥漫性胶质瘤新生血管生成中的作用。TAM表型与功能具有异质性,超出M1/M2炎症反应分型。文章总结TAM个体发生、调控肿瘤血管生成各过程的机制、介导当前抗血管治疗耐药的机制,以及临床试验中的新化合物和潜在治疗靶点。
要点
- TAM是恶性肿瘤中的重要细胞群体,参与肿瘤生长、转移和新生血管生成。
- TAM的表型和功能具有异质性,比M1/M2炎症反应分型所提示的更为复杂。
- 本文总结TAM调控肿瘤血管生成的机制及介导抗血管治疗耐药的机制。
核心结论
- 了解TAM在新生血管生成中的作用对未来的抗血管生成治疗具有重要意义。
研究设计与样本
- 本文为综述,聚焦弥漫性胶质瘤,总结TAM个体发生、在肿瘤血管生成调控中的作用、介导当前抗血管治疗耐药的机制、临床试验中的新化合物及潜在治疗靶点。
主要发现
- TAM表型与功能具有异质性,比M1/M2炎症反应分型所提示的更为复杂。
- TAM参与调控肿瘤血管生成的多个不同过程。
- TAM介导对当前抗血管治疗的耐药。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
"Tumor-associated macrophages" (TAMs) form a significant cell population in malignant tumors and contribute to tumor growth, metastasis, and neovascularization. Gliomas are characterized by extensive neo-angiogenesis, and knowledge of the role of TAMs in neovascularization is important for future anti-angiogenic therapies. The phenotypes and functions of TAMs are heterogeneous and more complex than a classification into M1 and M2 inflammation response types would suggest. In this review, we provide an update on the current knowledge of the ontogeny of TAMs, focusing on diffuse gliomas. The role of TAMs in the regulation of the different processes in tumor angiogenesis is highlighted and the most recently discovered mechanisms by which TAMs mediate resistance against current antivascular therapies are mentioned. Novel compounds tested in clinical trials are discussed and brought in relation to different TAM-related angiogenesis pathways. In addition, potential therapeutic targets used to intervene in TAM-regulated tumor angiogenesis are summarized.
引用
- Zhu C, Kros JM, Cheng C, et al. The contribution of tumor-associated macrophages in glioma neo-angiogenesis and implications for anti-angiogenic strategies. Neuro Oncol. 2017. PMID: 28575312. doi:10.1093/neuonc/nox081
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。